Group structure
8 companies in 5 countries
Loading your page…
Loading your page…
8 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Well-known pharmaceutical groups, each with all its companies.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
23 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Bromazepam Dr. Max1.5mg · tableta | Bromazepam | Serbia | Authorised | 2024 |
| Bromazepam Dr. Max3mg · tableta | Bromazepam | Serbia | Authorised | 2024 |
| EZETIMIBE MEDREGCompressa | Ezetimibe | Italy | Authorised | |
| LA MER THE SPF 50 UV PROTECTING FLUID3.0 % / w/w + 5.0 % / w/w + 5.0 % / w/w + 2.7 % / w/w + 3.0 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone | Canada | Marketed | 2014 |
| Orasept 0,6 mg/1,2 mg/2 mg zuigtablettenZuigtablet | Amylmetacresol, Dichloorbenzylalcohol, Lidocaine | Netherlands | Authorised | 2025 |
| Paracetamol Dr. Max500mg · tableta | Paracetamol | Serbia | Authorised | 2025 |
| ZOTRINA 3 MG PASTILLAS PARA CHUPAR SABOR LIMÓN3 mg · Pastilla para chupar | Benzydamine | Spain | Authorised | 2025 |
| ZOTRINA 3 MG PASTILLAS PARA CHUPAR SABOR MIEL Y NARANJA3 mg · Pastilla para chupar | Benzydamine | Spain | Authorised | 2025 |
| GINGIVITOL PAINT SOLUTION | Pantothenic acid, Glycerine, Hydrast, Tannicacid | Saudi Arabia | Authorised | |
| DIPYRONE 5050 % / w/v · Solution | Dipirona | Canada | Cancelled | 1997 |
| LA MER THE FLUID FOUNDATION SPF 152 % · Liquid | Octinoxate | Canada | Cancelled | 2003 |
| LA MER THE REPARATIVE BODY SUN LOTION SPF 303.0 % / w/w + 5.0 % / w/w + 5.0 % / w/w + 2.7 % / w/w + 3.0 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone | Canada | Cancelled | 2014 |
| LA MER THE REPARATIVE FACE SUN LOTION SPF 303.0 % / w/w + 5.0 % / w/w + 5.0 % / w/w + 2.7 % / w/w + 2.5 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone | Canada | Cancelled | 2014 |
| LA MER THE SOFT FLUID LONG WEAR FOUNDATION SPF 207.5 % / w/w + 1.9 % / w/w · Lotion | Octinoxate, Titanium dioxide | Canada | Cancelled | 2016 |
| LA MER THE SPF 18 FLUID3.0 % + 3.5 % + 7.5 % · Liquid | Avobenzone, Homosalate, Octinoxate | Canada | Cancelled | 2003 |
| LA MER THE SPF 18 FLUID TINT3.0 % + 3.5 % + 7.5 % · Lotion | Avobenzone, Homosalate, Octinoxate | Canada | Cancelled | 2006 |
| LA MER THE TREATMENT CREME FOUNDATION SPF 151.0 % + 5.4 % · Cream | Octinoxate, Titanium dioxide | Canada | Cancelled | 2006 |
| LA MER THE TREATMENT FLUID FOUNDATION SPF 152.2 % + 4.7 % · Liquid | Octinoxate, Titanium dioxide | Canada | Cancelled | 2006 |
| ONGUENT NOIR/BLACK OINTMENT2.55 % / w/w + 6 % / w/w · Ointment | Iodine, Methyl salicylate | Canada | Cancelled | 2001 |
| PHENYLBUTAZONE INJECTION200 mg / ml · Solution | Phenylbutazone | Canada | Cancelled | 1998 |
| THE RADIANT SKINTINT SPF 307.5 % + 2 % + 5.3 % · Lotion | Octinoxate, Octisalate, Titanium dioxide | Canada | Cancelled | 2015 |
| THE SOFT MOISTURE POWDER FOUNDATION SPF 305.1 % / w/w + 6 % / w/w · Powder | Octinoxate, Titanium dioxide | Canada | Cancelled | 2021 |
| VIT-E-AD100000 unit / ml + 10000 unit / ml + 300 unit / ml · Solution | Vitamin a, Vitamin d, Vitamin e | Canada | Cancelled | 1999 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 15 | 1 | 14 | CompaniesAll medicines |
| Serbia | 3 | 3 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
| Netherlands | 1 | 1 | 0 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only